Skip to main content

Table 4 Comparison of laboratory data between CHC patients with and without advanced liver fibrosis

From: Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy

Liver stiffness measurement  < F3 (n = 15)  ≥ F3 (n = 34) p value
ALT levels (U/L)
 Week 0 56.7 ± 48.0 97.3 ± 60.9 0.027
 Week 24 15.4 ± 9.0 32.3 ± 21.9 0.006
 Week 48 14.3 ± 6.1 24.5 ± 10.0 0.001
P3NP levels (ng/mL)
 Week 0 35.8 ± 12.1 49.0 ± 14.6 0.004
 Week 24 29.4 ± 13.4 38.7 ± 18.5 0.088
 Week 48 25.9 ± 5.9 39.3 ± 14.7 0.002
25(OH)VD levels (ng/mL)
 Week 0 26.8 ± 9.1 21.9 ± 6.4 0.036
 Week 24 19.2 ± 6.7 19.7 ± 5.2 0.816
 Week 48 22.3 ± 8.0 19.4 ± 6.5 0.206